Companies › ANTX

AN2 Therapeutics Inc (ANTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001880438 · EDGAR filings · Updated 2026-07-10

AN2 Therapeutics Inc (ANTX) has reported institutional ownership of 60.9%, with 52 institutional managers holding positions valued at $74.8M per the latest 13F reporting period.

Latest updates

• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-06-09 — Current report (8-K) filed
• 2026-06-04 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AN2 Therapeutics Inc has 52 institutional holders and institutional ownership of 60.9%.

Insider activity

Insiders reported 36 transactions (2 buys, 16 sells) across 12 reporting insiders, with a net reported value of −$3.12M.

Related companies

PROMIS NEUROSCIENCES INC (PMN) · APYX MEDICAL CORPORATION (APYX) · PROKIDNEY CORP (PROK) · SANUWAVE HEALTH INC (SNWV) · NOVABRIDGE BIOSCIENCES (NBP) · CARIBOU BIOSCIENCES INC (CRBU)